Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash flows from operating activities:
Net income (loss)	$ 107,515	$ (533)
Adjustments to reconcile net income (loss) to cash flows from operating activities:
Gain on sale of business	(176,162)	0
Impairment of goodwill, fixed assets and other intangibles	25,114	0
Unrealized losses on equity investments	28,077	0
Depreciation and amortization	14,206	18,437
Non-cash lease expense	6,438	7,987
Stock-based compensation	9,308	4,242
Inventory write-down	3,085	2,003
Foreign currency losses	931	1,639
Loss on disposal of assets	58	218
Deferred taxes	631	1,348
Changes in operating assets and liabilities:
Accounts receivable, net	(5,878)	7,447
Inventories, net	(32)	6,999
Prepaid expenses and other	9,612	(13,352)
Other assets	1,796	(4,295)
Accounts payable	(1,439)	(10,575)
Accrued expenses	(21,016)	(4,227)
Other liabilities	(1,855)	(14,020)
Net cash provided by operating activities	389	3,318
Cash flows from investing activities:
Purchases of property and equipment	(13,584)	(12,281)
Proceeds on investment sales	1,403	3,019
Proceeds from sale of business, net	193,725	0
Net cash provided by (used in) investing activities	181,544	(9,262)
Cash flows from financing activities:
Exercise of employee stock options and taxes paid related to the net shares settlement of stock awards	(1,162)	(1,891)
Payment of cash dividends	(3,002)	(2,979)
Repurchase of shares of common stock	(5,012)	0
Finance lease principal payments	(621)	(785)
Contingent consideration payments	0	(6,300)
Payments of debt	(155,000)	(20,000)
Other, net	(1,498)	0
Net cash used in financing activities	(166,295)	(31,955)
Effect of exchange rate changes on cash	1,249	(5,626)
Net increase (decrease) in cash and cash equivalents	16,887	(43,525)
Cash and cash equivalents, beginning of period	186,883	256,057
Cash and cash equivalents, end of period	$ 203,770	$ 212,532